Adaptimmune Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $351 | 2.7k | 0.13 |
| 2025-06-30 | $12k | 49k | 0.24 |
| 2025-03-31 | $7.9k | 41k | 0.20 |
| 2024-12-31 | $35k | 64k | 0.54 |
| 2024-09-30 | $64k | 67k | 0.95 |
| 2024-06-30 | $62k | 64k | 0.97 |
| 2024-03-31 | $86k | 54k | 1.58 |
| 2023-12-31 | $45k | 56k | 0.80 |
| 2023-09-30 | $43k | 55k | 0.78 |
| 2023-06-30 | $56k | 60k | 0.93 |
| 2022-12-31 | $9.1k | 6.2k | 1.46 |
| 2022-09-30 | $0 | 6.2k | 0.00 |
| 2022-06-30 | $0 | 6.2k | 0.00 |
| 2022-03-31 | $15k | 7.8k | 1.88 |
| 2021-12-31 | $20k | 5.4k | 3.76 |
| 2021-09-30 | $27k | 5.4k | 5.06 |
| 2021-06-30 | $78k | 16k | 5.00 |
| 2021-03-31 | $62k | 12k | 5.27 |
| 2020-12-31 | $40k | 7.2k | 5.64 |
| 2020-09-30 | $24k | 3.0k | 8.15 |
| 2020-06-30 | $20k | 1.9k | 10.03 |
| 2020-03-31 | $1.3k | 250 | 5.00 |
| 2019-12-31 | $0 | 250 | 0.00 |
| 2019-09-30 | $0 | 800 | 0.00 |
| 2019-06-30 | $4.0k | 800 | 5.00 |
| 2019-03-31 | $4.0k | 800 | 5.00 |
| 2018-12-31 | $10k | 2.0k | 5.00 |
| 2018-09-30 | $39k | 2.8k | 14.00 |
| 2018-06-30 | $42k | 4.2k | 10.00 |
| 2018-03-31 | $34k | 3.4k | 10.00 |
| 2017-12-31 | $9.5k | 1.9k | 5.00 |
| 2017-06-30 | $36k | 7.1k | 5.00 |
| 2017-03-31 | $38k | 7.6k | 5.00 |
| 2016-12-31 | $7.0k | 1.4k | 5.00 |
| 2016-09-30 | $7.0k | 1.4k | 5.00 |
| 2016-06-30 | $14k | 1.4k | 10.00 |
| 2016-03-31 | $8.0k | 800 | 10.00 |
| 2015-12-31 | $7.0k | 600 | 11.67 |
| 2015-09-30 | $7.0k | 600 | 11.67 |